BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 8284002)

  • 61. Asymptomatic duodenal ulcers occurring during maintenance treatment with ranitidine.
    Penston JG; Wormsley KG
    Aliment Pharmacol Ther; 1990 Dec; 4(6):569-76. PubMed ID: 2129644
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Dyspepsia: incidence of a non-ulcer disease in a controlled trial of ranitidine in general practice.
    Saunders JH; Oliver RJ; Higson DL
    Br Med J (Clin Res Ed); 1986 Mar; 292(6521):665-8. PubMed ID: 3081221
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Review of ulcer treatment: role of ranitidine.
    Boyd EJ; Wilson JA; Wormsley KG
    J Clin Gastroenterol; 1983; 5 Suppl 1():133-41. PubMed ID: 6317738
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Effects of treatment compliance and overnight gastric secretion on outcome of maintenance therapy of duodenal ulcer with ranitidine.
    Boyd EJ; Wilson JA; Wormsley KG
    Scand J Gastroenterol; 1983 Mar; 18(2):193-200. PubMed ID: 6324330
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Highly selective vagotomy and duodenal ulcers that fail to respond to H2 receptor antagonists.
    Primrose JN; Axon AT; Johnston D
    Br Med J (Clin Res Ed); 1988 Apr; 296(6628):1031-5. PubMed ID: 3130125
    [TBL] [Abstract][Full Text] [Related]  

  • 66. A comparison between enprostil and ranitidine in the management of gastric ulceration.
    Morgan AG; Pacsoo C; Taylor P; McAdam WA
    Aliment Pharmacol Ther; 1990 Dec; 4(6):635-41. PubMed ID: 2129650
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Effect of the H2-receptor antagonist ranitidine on depression and anxiety in duodenal ulcer patients.
    Robins AH; Lucke W; McFadyen ML; Wright JP
    Postgrad Med J; 1984 May; 60(703):353-5. PubMed ID: 6330716
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Does maintenance therapy keep duodenal ulcers healed?
    Boyd EJ; Penston JG; Johnston DA; Wormsley KG
    Lancet; 1988 Jun; 1(8598):1324-7. PubMed ID: 2897568
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Efficacy and safety of long-term maintenance therapy of duodenal ulcers.
    Penston J; Wormsley KG
    Scand J Gastroenterol; 1989 Nov; 24(9):1145-52. PubMed ID: 2595277
    [TBL] [Abstract][Full Text] [Related]  

  • 70. RUDER--a prospective, two-year, multicenter study of risk factors for duodenal ulcer relapse during maintenance therapy with ranitidine. RUDER Study Group.
    Armstrong D; Arnold R; Classen M; Fischer M; Goebell H; Schepp W; Blum AL
    Dig Dis Sci; 1994 Jul; 39(7):1425-33. PubMed ID: 8026252
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Clinical, controlled trial of somatostatin with ranitidine and placebo in the control of peptic hemorrhage of the upper gastrointestinal tract.
    Coraggio F; Bertini G; Catalano A; Scarpato P; Gualdieri L
    Digestion; 1989; 43(4):190-5. PubMed ID: 2575550
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Ranitidine maintenance treatment of non-steroidal anti-inflammatory drug-induced duodenal ulceration.
    Penston JG; Wormsley KG
    Aliment Pharmacol Ther; 1989 Oct; 3(5):499-503. PubMed ID: 2518863
    [TBL] [Abstract][Full Text] [Related]  

  • 73. [Ranitidine: a new histamine H2 receptor blockader].
    Duan ZB
    Zhonghua Nei Ke Za Zhi; 1986 May; 25(5):309-12. PubMed ID: 2874962
    [No Abstract]   [Full Text] [Related]  

  • 74. [Ranitidine and cimetidine in the prevention of stress: ulcer hemorrhage a prospective comparative multicenter study].
    Barth HO; Berg P; Brunner G; Dammann HG; Friedl W; Franken FH; Greiner L; Groitl J; Möckel W; Müller P
    Langenbecks Arch Chir; 1984; 362(2):131-8. PubMed ID: 6330478
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Prevention of gastrointestinal bleeding after a cardiac operation.
    Stchepinsky OA; Theodose YV; Huisman JP; Gaultier YM; Maas HE
    Ann Thorac Surg; 1998 Jul; 66(1):306-7. PubMed ID: 9692506
    [No Abstract]   [Full Text] [Related]  

  • 76. [Significance of duodenal stasis in the etiology of recurrent hemorrhage in duodenal ulcer].
    Zaĭtsev VT; Boĭko VV; Savvi SA; Taraban IA
    Klin Khir; 1998; (12):3-4. PubMed ID: 10077932
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Prophylaxis of gastrointestinal tract bleeding with magaldrate in patients admitted to a general hospital ward.
    Estruch R; Pedrol E; Castells A; Masanés F; Marrades RM; Urbano-Márquez A
    Scand J Gastroenterol; 1991 Aug; 26(8):819-26. PubMed ID: 1771386
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Economic analysis of maintenance treatment with ranitidine 150 mg in duodenal ulcer].
    Ruszniewski P; Levy E; Mignon M
    Gastroenterol Clin Biol; 1992; 16(11):842-7. PubMed ID: 1483552
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Seasonal changes in symptomatic duodenal ulcer activity in Taiwan: a comparison between subjects with and without haemorrhage.
    Tsai CJ; Lin CY
    J Intern Med; 1998 Nov; 244(5):405-10. PubMed ID: 9845856
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Prevention of upper gastrointestinal bleeding.
    Peterson WL
    N Engl J Med; 1994 Feb; 330(6):428-9. PubMed ID: 8284010
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.